This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Europe


  • 00
  • 00
  • 00
  • 00
Delivered as a Hybrid Event, 7 - 9 June, 2022
Live In-Person Event: 7 - 9 June, Postillion Hotel AmsterdamDigital Experience: All Sessions Livestreamed 7 - 9 June

Matt Baker
Senior Director, Strategy and Business Development at Thermo Fisher Scientific


Matt joined Thermo Fisher Scientific in 2008 and currently leads business development and strategy for their Protein and Cell Analysis business.  Over his more than 25-year career, he has focused extensively on developing and characterizing antibodies.  Most recently, Matt helped support and organize an international initiative with Mathias Uhlen and other leading researchers to better validate antibodies through establishing standards on antibody specificity and applications testing.  He continues to play key roles in supporting organizations and promoting standards that help scientists be more successful in their research through better validation and testing.

Agenda Sessions

  • Antibodies Are Only As Good As You Validate Them